The aim of this work was to develop and characterize nanocomposite thin films containing silver nanoparticles (AgNPs), as wound dressings and antifungal materials, using a green process for the nanoparticles' synthesis and a single step procedure for the preparation of the nanocomposite films. To this end, polyphenol-rich extracts obtained from kiwi peels, an agri-food industrial by-product, were used as a reducing agent of silver nitrate salt. The AgNPs were let form within the film-forming solution, which was composed by low acyl gellan gum and a plasticizing agent (glycerol or PEG 400 g/mol) and the corresponding nanocomposite films were deposited by the solvent casting technique. The plasticizing agent affected the AgNPs distribution within the films, as observed by SEM and EDS analyses, and consequently their tensile behaviour. In specific, AgNPs act as stress intensifiers in the presence of glycerol, whereas they act as film reinforcement with PEG400. However, both glycerol-plasticized and PEG400-plasticized films exhibited similar antifungal efficacy against 16 clinical isolates of 5 different Candida spp (C. albicans, C. lusitaniae, C. haemulonii, C. krusei and C. glabrata). Globally, the present study provides a green and single-step procedure to develop nanocomposite films embedding AgNPs obtained by in situ reduction of silver ions with polyphenol-rich extracts.
No takes yet. Share an insight, caveat, or question.
Muzio et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: